FDA expands use of Regeneron's HoFH drug Evkeeza to kids 5 and up

FDA expands use of Regeneron's HoFH drug Evkeeza to kids 5 and up

Submitted by admin on March 22, 2023 - 11:14am
Source: 
Fierce Pharma
News Tags: 
Regeneron
Evkeeza
pediatric
Homozygous Familial Hypercholesterolemia
FDA
Headline: 
FDA expands use of Regeneron's HoFH drug Evkeeza to kids 5 and up
snippet: 

One day after gaining a pediatric approval in Europe for Dupixent, Regeneron has earned an FDA nod for the use of Evkeeza in children ages 5 through 11 with homozygous familial hypercholesterolemia (HoFH).

Do Not Allow Advertisers to Use My Personal information